Home The Word Brain My Amedeo FAQ Privacy About


Hanzi Hunter

Learning 500 Chinese characters in 30 days is possible.

Abstract • About

  Cervical Cancer

  Free Subscription


02.03.2026

1 Am J Epidemiol
1 Ann Glob Health
1 Anticancer Res
1 Arch Biochem Biophys
2 Arch Pathol Lab Med
1 Biochem Pharmacol
1 BMC Cancer
1 BMC Immunol
1 BMJ
2 Brachytherapy
1 Cancer Cell Int
1 Cancer Epidemiol
1 Cancer Treat Res Commun
3 Cancers (Basel)
1 Case Rep Womens Health
1 Cell Death Dis
1 Clin Transl Oncol
3 Cureus
1 Curr Drug Targets
2 Curr Oncol
1 Eur J Cancer
1 Eur J Surg Oncol
1 Front Immunol
1 Front Med (Lausanne)
1 Front Oncol
2 Front Pharmacol
1 Front Public Health
1 Front Surg
3 Gynecol Oncol
1 Gynecol Oncol Rep
2 Health Sci Rep
1 HIV AIDS (Auckl)
1 Immunotargets Ther
1 Implement Sci Commun
1 Int J Cancer
1 Int J Clin Oncol
1 Int J Mol Sci
1 Int J Surg
1 J Clin Med
3 J Contemp Brachytherapy
1 J Epidemiol Glob Health
1 J Low Genit Tract Dis
1 J Mater Chem B
1 J Mol Histol
1 J Natl Cancer Inst
1 J Womens Health (Larchmt)
1 JAMA
1 Medicina (Kaunas)
3 Medicine (Baltimore)
1 Nanomedicine
1 Obstet Gynecol
1 Oncogenesis
1 Oncol Lett
2 Open Life Sci
1 Palliat Support Care
1 Pharmacoeconomics
1 Phys Imaging Radiat Oncol
1 PLoS One
1 Prev Med Rep
1 Public Health Rep
1 Radiol Imaging Cancer
2 Sci Rep
1 Trials
1 Tumori
1 Womens Health (Lond)


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Epidemiol

  1. SCHULTE-FROHLINDE R, Georges D, Clifford G, Baussano I, et al
    Correction to "Predicting cohort-specific cervical cancer incidence from population-based surveys of human papilloma virus prevalence: a worldwide study".
    Am J Epidemiol. 2026 Feb 27:kwae310. doi: 10.1093.
    PubMed        


    Ann Glob Health

  2. FRANCIS DL
    Maternal Cancer Mortality and Orphanhood: A Neglected Global Health and Equity Challenge.
    Ann Glob Health. 2026;92:18.
    PubMed         Abstract available


    Anticancer Res

  3. TONOMURA N, Yoshida K, Morita H, Nakai M, et al
    Diuretic Administration for Vomiting During Concurrent Chemoradiotherapy for Cervical Cancer: A Multicenter Retrospective Study.
    Anticancer Res. 2026;46:1497-1506.
    PubMed         Abstract available


    Arch Biochem Biophys

  4. LI W, Liang X, Wu X, Zheng B, et al
    RHBDD1 promotes cervical cancer progression by activating the EGFR/PI3K/AKT signaling pathway.
    Arch Biochem Biophys. 2026 Feb 25:110777. doi: 10.1016/j.abb.2026.110777.
    PubMed         Abstract available


    Arch Pathol Lab Med

  5. GOYAL A, Davey DD, Souers RJ, Roberson J, et al
    Practice Patterns Regarding Quality Assurance Measures in Gynecologic Cytology: Survey Results of Laboratories Participating in the 2022 College of American Pathologists PAP Education Program.
    Arch Pathol Lab Med. 2025;150:194-201.
    PubMed         Abstract available

  6. MILLS AM
    Biomarkers in Cervical Squamous Neoplasia: Diagnostic, Prognostic, and Predictive.
    Arch Pathol Lab Med. 2025;150:e46-e55.
    PubMed         Abstract available


    Biochem Pharmacol

  7. LIU X, Xu T, Wu J, Zhou B, et al
    RNA polymerase I inhibitor CX-5461 suppresses cervical cancer cell growth by inducing DNA damage and mitotic catastrophe and enhances cisplatin sensitivity.
    Biochem Pharmacol. 2026;248:117828.
    PubMed         Abstract available


    BMC Cancer

  8. BONNAH J, Awuah B, Williams MS
    The role of healthcare providers in shared decision making for cervical cancer prevention in Ghana: A qualitative study.
    BMC Cancer. 2026 Feb 27. doi: 10.1186/s12885-026-15785.
    PubMed        


    BMC Immunol

  9. JIAO Y, He Y, Zhao B, Sha L, et al
    The correlation between the systemic immune-inflammation index and relapse and metastasis in cervical squamous cell carcinoma patients over 50 years and older.
    BMC Immunol. 2026;27:20.
    PubMed         Abstract available


    BMJ

  10. WU S, Deng Y, Lepp T, Ask LS, et al
    Extended follow-up of invasive cervical cancer risk after quadrivalent HPV vaccination: nationwide, register based study.
    BMJ. 2026;392:e087326.
    PubMed         Abstract available


    Brachytherapy

  11. MITTAL P, Kamalnath J, Charnalia M, Anjana AK, et al
    Point S (sigmoid) doses and correlation with late recto-sigmoid adverse events in patients undergoing image-based brachytherapy for cervical cancer: clinical outcomes.
    Brachytherapy. 2026 Feb 25:S1538-4721(25)00394.
    PubMed         Abstract available

  12. OLIVA PJ, Ghosh S, Huang F, Wiebe E, et al
    Towards robust deep learning-based autosegmentation in MRI-planned gynecological brachytherapy: Importance of scalable development and comprehensive evaluation.
    Brachytherapy. 2026;25:361-372.
    PubMed         Abstract available


    Cancer Cell Int

  13. BABATUNDE AN, Aroba OJ, Adeniyi AE, Isiaka SO, et al
    Joint segmentation and classification of cervical cells using U-Net and CNN ensemble for early detection of cervical cancer.
    Cancer Cell Int. 2026 Feb 25. doi: 10.1186/s12935-026-04234.
    PubMed        


    Cancer Epidemiol

  14. BOUGHRIOU M, Zendehdel K, Lotfi F, Gorgati E, et al
    Cervical cancer in foreign-born women living in Italy: A systematic review of population-based studies.
    Cancer Epidemiol. 2026;102:103029.
    PubMed         Abstract available


    Cancer Treat Res Commun

  15. YIHEYIS MM, Yeheyis MM, Dessie MG, Anagaw YK, et al
    Exploring knowledge, attitudes, and practices on cervical cancer screening and their associated factors among female university students at Debre Markos University, Ethiopia.
    Cancer Treat Res Commun. 2026;47:101147.
    PubMed         Abstract available


    Cancers (Basel)

  16. REZENDE B, Wolf B, Colman V, Oliveira R, et al
    FIGO 2018 Versus Ontogenetic Staging for Locally Advanced Cervical Cancer: An International Multicenter Cohort Study Comparing the Two Classifications and Their Prognostic Implications.
    Cancers (Basel). 2026;18:689.
    PubMed         Abstract available

  17. MULUGETA-GORDON L, Jang M, Dagher C, Nasioudis D, et al
    Advances in the Surgical Management of Cervical Cancer.
    Cancers (Basel). 2026;18:628.
    PubMed         Abstract available

  18. YOUSSEF J, El Masri A, Atwi M, Ibrahim E, et al
    Molecular Targets of Cervical Cancer and Its Microenvironment: Advances in Treatment.
    Cancers (Basel). 2026;18:563.
    PubMed         Abstract available


    Case Rep Womens Health

  19. KUSAKABE H, Fukutome T, Suzuki H, Teramoto Y, et al
    Single-organ vasculitis of the uterine cervix mimicking cervical cancer: A case report.
    Case Rep Womens Health. 2026;49:e00787.
    PubMed         Abstract available


    Cell Death Dis

  20. FU F, Wang T, Wu Z, Feng Y, et al
    Retraction Note: HMGA1 exacerbates tumor growth through regulating the cell cycle and accelerates migration/invasion via targeting miR-221/222 in cervical cancer.
    Cell Death Dis. 2026;17:232.
    PubMed        


    Clin Transl Oncol

  21. ALREDHA RDA, Hussein TN, Alzerfi HSR, Haddawi KH, et al
    Evaluation of serum Cytokeratin 5 and p63 as non-invasive biomarkers for the diagnosis and staging of cervical cancer: a case-control study.
    Clin Transl Oncol. 2026 Feb 21. doi: 10.1007/s12094-026-04238.
    PubMed         Abstract available


    Cureus

  22. DASGUPTA S
    Efficiency of Human Papillomavirus (HPV) Testing in Cervical Cancer Screening and Vaccination: A Review.
    Cureus. 2026;18:e102126.
    PubMed         Abstract available

  23. SINGH N, Raj Jalagam V, Somagattu S, Kunwar S, et al
    Role of Training Paramedical Staff for Cervical Cancer Screening via Human Papillomavirus Self-Sampling in Remote Mountainous Regions: A Pilot Feasibility Study.
    Cureus. 2026;18:e102046.
    PubMed         Abstract available

  24. SHARMA V, Gupta N, Leger PD, Ryan WT, et al
    Asymptomatic Cervical Cancer Recurrence Presenting As Gastric Metastasis: A Report of a Rare Case.
    Cureus. 2026;18:e102001.
    PubMed         Abstract available


    Curr Drug Targets

  25. KUMAR V, Bharti N, Ranjan R, Pal RR, et al
    CRISPR-Cas9 Gene Editing: Promising Therapeutics for HPV-driven Cervical Cancer.
    Curr Drug Targets. 2026 Feb 23. doi: 10.2174/0113894501437052251204164311.
    PubMed        


    Curr Oncol

  26. ZHANG Y, Zhang J, Zhong M, Yu L, et al
    A Novel Three-Dimension Printed Individualized Curved-Needle-Based Interstitial Brachytherapy for Re-Irradiation in Uterine Fundus-Involving Recurrent Cervical Cancer: A Case Report.
    Curr Oncol. 2026;33:108.
    PubMed         Abstract available

  27. MERCIER NB, Khudina Y, Roberts L, Feely A, et al
    Surgically Treated Cervical Cancer in Manitoba: A Retrospective Study of the Impact of Geography on Care.
    Curr Oncol. 2026;33:70.
    PubMed         Abstract available


    Eur J Cancer

  28. SCHEVENHOVEN VJC, Jansen EEL, Siebers AG, de Kok IMCM, et al
    Long-term cervical cancer risk following negative hrHPV-based versus negative cytology-based screening: A population-based study.
    Eur J Cancer. 2026;237:116601.
    PubMed         Abstract available


    Eur J Surg Oncol

  29. BERTOLAZZI M, Genta ML, Lopes A, Fernandes R, et al
    Randomized trial of autologous ovarian graft to preserve ovarian function in young women undergoing pelvic radiotherapy for cervical cancer.
    Eur J Surg Oncol. 2026;52:111496.
    PubMed         Abstract available


    Front Immunol

  30. ZIDI S, Yacoubi-Loueslati B, Ben Abdelmoumen Mardassi B, Almawi WY, et al
    A machine learning approach to a nine-SNP immunogenetic score for prognostic stratification in cervical cancer.
    Front Immunol. 2026;17:1759674.
    PubMed         Abstract available


    Front Med (Lausanne)

  31. XIONG J, Qian Y, Wang M, Sun X, et al
    Factors associated with cervical cancer screening participation in Southwest China: a retrospective database-based cross-sectional study.
    Front Med (Lausanne). 2026;13:1740068.
    PubMed         Abstract available


    Front Oncol

  32. SUN F, Ge X, Deng L, Wang Y, et al
    Research on a method for early diagnosis and progression prediction of cervical cancer based on imaging omics and molecular omics.
    Front Oncol. 2026;15:1670852.
    PubMed         Abstract available


    Front Pharmacol

  33. XIAMUXI H, Deng X, Ablise M, Yan T, et al
    A novel pyrrolidine-chalcone derivative exhibits synergistic anti-cervical cancer activity by dual-targeting MDM2-p53 axis and ferroptosis pathway.
    Front Pharmacol. 2026;17:1715712.
    PubMed         Abstract available

  34. PANDEY P, Hussain A, Khan F
    Editorial: Plant bioactive compounds as modulators of oncogenic signalling pathways in cervical cancer.
    Front Pharmacol. 2026;17:1788689.
    PubMed        


    Front Public Health

  35. ZHAO X, Zhang X, Xu Y, Huang Y, et al
    Awareness of HPV, HPV vaccine and associated factors among male junior high school students in Zhejiang Province, China.
    Front Public Health. 2026;14:1727798.
    PubMed         Abstract available


    Front Surg

  36. SHI R, Hou W, Gao Y, Sun S, et al
    Meta-analysis of risk factors for recurrence in cervical cancer patients following fertility-sparing treatment.
    Front Surg. 2026;12:1625067.
    PubMed         Abstract available


    Gynecol Oncol

  37. NAUMANN RW
    Commentary on: Comparative outcomes of simple versus radical hysterectomy in patients with and without very low-risk early-stage cervical cancer: An exploratory analysis from the Gynecologic Cancer Intergroup Canadian Cancer Trials Group Cx.5/SHAPE tr
    Gynecol Oncol. 2026;205:A1-A2.
    PubMed        

  38. CUTRI-FRENCH C, Saris DH, Solorzano SS, Wang X, et al
    Disparities in access to gynecologic oncology visits among elderly patients with gynecologic malignancies.
    Gynecol Oncol. 2026;205:63-69.
    PubMed         Abstract available

  39. JAIN D, Wahidi M, Effendi J, Hoang L, et al
    Survival comparison analysis between cervical squamous cell carcinoma and adenocarcinoma with a special focus on the HPV status.
    Gynecol Oncol. 2026;205:89-98.
    PubMed         Abstract available


    Gynecol Oncol Rep

  40. LEE SS, Boitano TKL, Hutchcraft ML, Modesitt SC, et al
    #DidYouKnow: Physician engagement online and offline is mission critical to promote accurate and impactful cervical cancer information dissemination.
    Gynecol Oncol Rep. 2026;63:102042.
    PubMed        


    Health Sci Rep

  41. ABUBAKARI AK, Gross J, Adusei-Poku E
    Understanding Cervical Cancer Screening Intentions Through the Lens of Care-Seeking Behavior: A Cross-Sectional Study Among Islamic Women in Ghana.
    Health Sci Rep. 2026;9:e71827.
    PubMed         Abstract available

  42. RIPON RK, Hossain MJ, Prasad NG, Thakkar N, et al
    Cervical Cancer, HPV, and HPV Vaccine Knowledge and Willingness to be Vaccinated Among Adolescent Girls in Dhaka, Bangladesh: A Cross-Sectional Study.
    Health Sci Rep. 2026;9:e71843.
    PubMed         Abstract available


    HIV AIDS (Auckl)

  43. ZORRILLA CD, Olmo-Lopez CV, Hernandez Garayua AM, Ibarra J, et al
    Associations of HIV RNA Viral Load, CD4 Counts, HPV Detection, and Cytology Support Co-Testing for Cervical Cancer Screening Among Women Living with HIV.
    HIV AIDS (Auckl). 2026;18:553851.
    PubMed         Abstract available


    Immunotargets Ther

  44. GU H, Hu B, Jiang Y
    The Comparative Effectiveness of Enlonstobart and Camrelizumab as Second-Line Recurrent or Metastatic Cervical Cancer Therapies: Matching-Adjusted and Simulated Treatment Comparisons.
    Immunotargets Ther. 2026;15:572970.
    PubMed         Abstract available


    Implement Sci Commun

  45. ADHIAMBO HF, Thomas K, Coe MM, Oluoch L, et al
    Applying FRAME-IS to characterize provider-led adaptations to a cervical cancer prevention intervention in Kenya.
    Implement Sci Commun. 2026 Feb 24. doi: 10.1186/s43058-026-00883.
    PubMed         Abstract available


    Int J Cancer

  46. NEWTON R, Tenet V, Mugisha J, Kimono B, et al
    Human papillomavirus infection and vaccination among young females in rural Uganda.
    Int J Cancer. 2025 Nov 6. doi: 10.1002/ijc.70227.
    PubMed         Abstract available


    Int J Clin Oncol

  47. NISHIOKA K, Sekiyama K, Shiro R, Tsunoda I, et al
    Lack of molecular mimicry between HPV vaccine L1 antigen and human proteins by a computational analysis.
    Int J Clin Oncol. 2026;31:494-503.
    PubMed         Abstract available


    Int J Mol Sci

  48. JULIANTI RA, Putra AD, Fuady A, Nuranna L, et al
    Expression of miR-92a and miR-125b and Their Association with Chemoradiotherapy Response in Locally Advanced Cervical Cancer.
    Int J Mol Sci. 2026;27:1723.
    PubMed         Abstract available


    Int J Surg

  49. SUN M, Zhou H, Chen J
    Reappraising the clinical value of adjuvant chemoradiotherapy in intermediate-risk cervical cancer: beyond statistical significance.
    Int J Surg. 2026;112:5267-5268.
    PubMed        


    J Clin Med

  50. ILIA G, Thomopoulos A, Chronas D
    Preserved Menstruation After Chemoradiotherapy in Stage IIIC1 Cervical Cancer: A Unique Case.
    J Clin Med. 2026;15:1550.
    PubMed         Abstract available


    J Contemp Brachytherapy

  51. MAHE L, Cagetti LV, Myxa J, Gonzague-Casabianca L, et al
    Dosimetric comparison between manual and inverse optimization methods in high-dose-rate intracavitary/ interstitial cervical cancer brachytherapy for two treatment planning systems.
    J Contemp Brachytherapy. 2025;17:400-406.
    PubMed         Abstract available

  52. KILAR CR, Bajwa HK, Pifer PM, Beriwal S, et al
    Selection of hybrid applicators for adaptive cervical cancer brachytherapy: A practical guide.
    J Contemp Brachytherapy. 2025;17:390-399.
    PubMed         Abstract available


  53. Erratum to the article: Pre-treatment T2-weighted magnetic resonance radiomics for prediction of loco-regional recurrence after image-guided adaptive brachytherapy for locally advanced cervical cancer. Authors: Pittaya Dankulchai, Natthakorn Thanamits
    J Contemp Brachytherapy. 2025;17:421.
    PubMed         Abstract available


    J Epidemiol Glob Health

  54. DIRIE NI, Hassan MM, Ahmed MM, Hassan J, et al
    Current Cervical Cancer Status in Resource-Limited Somalia: a Systematic Review of Burden, Screening Findings, and Knowledge Gaps.
    J Epidemiol Glob Health. 2026;16:22.
    PubMed        


    J Low Genit Tract Dis

  55. PECK LC, Petty MC, Walker AR, Huepenbecker SP, et al
    Adherence to 2019 ASCCP Cervical Cancer Screening Guidelines at a Community Health Network.
    J Low Genit Tract Dis. 2026 Feb 27. doi: 10.1097/LGT.0000000000000938.
    PubMed         Abstract available


    J Mater Chem B

  56. LI J, Chu C, Zhu L, Du Z, et al
    NIR-activated dual-mode oxygen-generating and -delivering nanoplatform for enhanced photodynamic therapy of cervical cancer.
    J Mater Chem B. 2026 Feb 25. doi: 10.1039/d5tb02652.
    PubMed         Abstract available


    J Mol Histol

  57. ZHAO Y, Sha Z, An T, Wang W, et al
    TMEM130 promoter hypermethylation predicts tumor cell migration in cervical cancer.
    J Mol Histol. 2026;57:83.
    PubMed         Abstract available


    J Natl Cancer Inst

  58. JIANG C, Rosenberg PS, Star J, Bandi P, et al
    State-level progress in reducing cervical cancer incidence among US young women between the pre- and post-human papillomavirus vaccination eras.
    J Natl Cancer Inst. 2026 Feb 24:djag051. doi: 10.1093.
    PubMed         Abstract available


    J Womens Health (Larchmt)

  59. HUYNH GT, Li A, Nims L, Seiler J, et al
    Intimate Partner Violence and Cervical, Breast, and Colorectal Cancer Screening: Findings from the Washington State Behavioral Risk Factor Surveillance System.
    J Womens Health (Larchmt). 2026;35:413-420.
    PubMed         Abstract available


    JAMA

  60. ANDERER S
    At-Home Cervical Cancer Screening Favored by Certain Groups.
    JAMA. 2026 Feb 20. doi: 10.1001/jama.2025.26399.
    PubMed        


    Medicina (Kaunas)

  61. PRASERTPAKDI S, Suprasert P, Salakphet T, Khunamornpong S, et al
    Cervical Cancer Screening: Histologic Outcomes of HPV-Negative HSIL/ASC-H Cytology in a Tertiary Referral Cohort in Northern Thailand.
    Medicina (Kaunas). 2026;62:371.
    PubMed         Abstract available


    Medicine (Baltimore)

  62. GE Z, Zhang C, Zhang Z, Li J, et al
    The causal effect of cytokine cycling levels on the risk of cervical cancer: A bidirectional 2-sample Mendelian randomization study.
    Medicine (Baltimore). 2026;105:e47782.
    PubMed         Abstract available

  63. JOSHI M, Rajbanshi M, Rana A, Thapa S, et al
    Awareness of cervical cancer, practice of cervical cancer screening and its associated factors among reproductive-aged women in Shankharapur Municipality of Kathmandu district, Nepal: A cross-sectional study.
    Medicine (Baltimore). 2026;105:e47729.
    PubMed         Abstract available

  64. CHEN C, Wang S, Liu J, Liao J, et al
    Bone marrow function in cervical cancer patients after concurrent chemoradiotherapy using 99mTc-SC SPECT/CT: A cross-sectional retrospective study.
    Medicine (Baltimore). 2026;105:e47766.
    PubMed         Abstract available


    Nanomedicine

  65. SINGH S, Batra N, Mittal S
    Emerging nanocarrier platforms in cervical cancer therapy: From molecular targeting to precision nanomedicine.
    Nanomedicine. 2026 Feb 21:102913. doi: 10.1016/j.nano.2026.102913.
    PubMed         Abstract available


    Obstet Gynecol

  66. MAYBURY EK, Ahmad S, McKenzie ND
    Worldwide Evaluation of Cervical Cancer Self-Sampling Devices.
    Obstet Gynecol. 2026 Feb 26. doi: 10.1097/AOG.0000000000006179.
    PubMed         Abstract available


    Oncogenesis

  67. SHEN T, Ma Y, Wu T, Cao Z, et al
    Human papillomavirus16 E7 enhances cell stemness by regulating the APC2/SPIN4/beta-catenin axis in cervical cancer.
    Oncogenesis. 2026 Feb 24. doi: 10.1038/s41389-026-00602.
    PubMed         Abstract available


    Oncol Lett

  68. WANG R, Ning L, Li X, Xu Y, et al
    Lactylation-based machine algorithm combined with multi-omics analysis to predict prognosis in cervical cancer.
    Oncol Lett. 2026;31:133.
    PubMed         Abstract available


    Open Life Sci

  69. XUE J, Xiao H, Ren X, Yang Q, et al
    Low-molecular-weight metabolites from lactic acid bacteria suppress cervical cancer progression by inhibiting EMT via the Wnt/beta-catenin pathway.
    Open Life Sci. 2026;21:20251264.
    PubMed         Abstract available

  70. TIAN X, Yang H
    Development of bioengineered SPIONs using Carica monoica extract: evaluation of antioxidant and anticancer activity of human cervical cancer cells (SiHa).
    Open Life Sci. 2026;21:20251258.
    PubMed         Abstract available


    Palliat Support Care

  71. SULEMAN DB, Folorunsho S
    Cervical cancer research disparities among African immigrant women in the United States: A systematic review.
    Palliat Support Care. 2026;24:e68.
    PubMed         Abstract available


    Pharmacoeconomics

  72. FU X, Zhang Q, Wagner AL, Yao Y, et al
    Public Health Impact and Cost-Effectiveness of Routine and Catch-Up Human Papillomavirus Vaccination in Girls and Women in Selected Regions of China: A Model-Based Study.
    Pharmacoeconomics. 2026;44:343-357.
    PubMed         Abstract available


    Phys Imaging Radiat Oncol

  73. LI F, Ding S, Chen Z, Chen K, et al
    Potential of margin reduction for cervical cancer radiotherapy in an online adaptive image-guided workflow.
    Phys Imaging Radiat Oncol. 2026;37:100923.
    PubMed         Abstract available


    PLoS One


  74. Retraction: Design and validation of ultra-compact metamaterial-based biosensor for non-invasive cervical cancer diagnosis in terahertz regime.
    PLoS One. 2026;21:e0343674.
    PubMed        


    Prev Med Rep

  75. FOUCAULT E, Macioce V, Soler M, Pers YM, et al
    Adherence to breast and cervical cancer screening guidelines according to obesity status: a French cross-sectional multicenter survey.
    Prev Med Rep. 2026;63:103405.
    PubMed         Abstract available


    Public Health Rep

  76. BERMUDEZ Y, Miller J, Kenney K, Schlueter D, et al
    Predictors of Breast Cancer Screening Variability Among National Breast and Cervical Cancer Early Detection Program Awardees: Provider Shortages and Nurse Practitioner Autonomy.
    Public Health Rep. 2026 Feb 22:333549261421878. doi: 10.1177/00333549261421878.
    PubMed         Abstract available


    Radiol Imaging Cancer

  77. MENG N, Pan J, Wei W, Sun J, et al
    Lymph Node Metastases Prediction in Cervical Cancer Using Time-Dependent Diffusion MRI and Macromolecular Proton Fraction Imaging.
    Radiol Imaging Cancer. 2026;8:e250452.
    PubMed         Abstract available


    Sci Rep

  78. ZHAO X, Yang L, Pan J, Zeng Z, et al
    Correction: CXCL8 modulates M0 macrophage proliferation and polarization to influence tumor progression in cervical cancer.
    Sci Rep. 2026;16:7718.
    PubMed        

  79. KARAMI P, Yahya SI, Roshani S, Parandin F, et al
    Enhanced design of a photonic crystal biosensor for early cervical cancer detection using refractive index variation and neural network classification.
    Sci Rep. 2026 Feb 26. doi: 10.1038/s41598-026-41676.
    PubMed        


    Trials

  80. MOUSAVI-NEJAD S, Rezaei E, Nourizadeh R, Mohammadzadeh Z, et al
    The effect of Fogg model-based virtual education on health literacy and stages of behavior change in cervical cancer screening: study protocol for a randomized controlled trial.
    Trials. 2026 Feb 24. doi: 10.1186/s13063-026-09574.
    PubMed         Abstract available


    Tumori

  81. BOGANI G, Sopracordevole F, Corso G, Vizza E, et al
    Expectant management or conization for persistent low-grade cervical intraepithelial neoplasia: Analysis of 5-year outcomes.
    Tumori. 2026;112:75-82.
    PubMed         Abstract available


    Womens Health (Lond)

  82. MALIKOVA H, Graffneter K, Kremenova K, Burgetova R, et al
    Pretreatment computed tomography L1 attenuation values: Easy reaching predicting factor for radiation-related bone insufficiency fractures in females treated for advanced cervical cancer (prospective study).
    Womens Health (Lond). 2026;22:17455057261426799.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum